<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://tan.sagepub.com/">
<title>: Most-Read Full-Text Articles</title>
<link>http://tan.sagepub.com/</link>
<description>Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2009-11-09</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/1/33?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/3/163?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/5/327?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/4/215?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/4/261?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/4/223?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/1/25?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/5/337?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/4/241?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/1/43?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/1/13?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/3/155?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/3/181?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/5/299?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/1/13?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/1/5?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/5/313?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/5/319?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/2/79?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/4/195?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609347123v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/1/51?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/2/115?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/1/31?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/2/115?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/4/205?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/2/99?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/2/93?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/3/167?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/5/291?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/2/75?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/2/105?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/3/181?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/1/7?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/3/157?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/2/67?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609337975v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609337976v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/2/125?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/3/193?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609339382v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609348902v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/2/67?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/3/143?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609349521v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609344375v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/2/1/3?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609339383v2?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1756285609343480v1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://tan.sagepub.com/cgi/content/short/1/1/3?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/1/33?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Innovative monoclonal antibody therapies in multiple sclerosis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/1/33?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ralf A. Linker, Bernd C. Kieseier<br />Jul  1, 2008; 1:33-42<br />Article]]></description>
<dc:creator>Ralf A. Linker, Bernd C. Kieseier</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:identifier>10.1177/1756285608093945</dc:identifier>
<dc:title><![CDATA[Review: Innovative monoclonal antibody therapies in multiple sclerosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/3/163?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Therapy for Alzheimer's disease: how effective are current treatments?]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/3/163?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Krista L. Lanctot, Ryan D. Rajaram, Nathan Herrmann<br />May  1, 2009; 2:163-180<br />Article]]></description>
<dc:creator>Krista L. Lanctot, Ryan D. Rajaram, Nathan Herrmann</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:identifier>10.1177/1756285609102724</dc:identifier>
<dc:title><![CDATA[Review: Therapy for Alzheimer's disease: how effective are current treatments?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/5/327?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Menstrual migraine: therapeutic approaches]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/5/327?rss=1&amp;ssource=mfc</link>
<description><![CDATA[E. Anne MacGregor<br />Sep  1, 2009; 2:327-336<br />Article]]></description>
<dc:creator>E. Anne MacGregor</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Review: Menstrual migraine: therapeutic approaches]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/4/215?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Diagnosis and management of essential tremor and dystonic tremor]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/4/215?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Alexandre Gironell, Jaime Kulisevsky<br />Jul  1, 2009; 2:215-222<br />Article]]></description>
<dc:creator>Alexandre Gironell, Jaime Kulisevsky</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Review: Diagnosis and management of essential tremor and dystonic tremor]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/4/261?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Pathogenesis and treatment of immune-mediated neuropathies]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/4/261?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Helmar C. Lehmann, Gerd Meyer zu Horste, Bernd C. Kieseier, Hans-Peter Hartung<br />Jul  1, 2009; 2:261-281<br />Article]]></description>
<dc:creator>Helmar C. Lehmann, Gerd Meyer zu Horste, Bernd C. Kieseier, Hans-Peter Hartung</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Review: Pathogenesis and treatment of immune-mediated neuropathies]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/4/223?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Current treatment of vestibular, ocular motor disorders and nystagmus]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/4/223?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Michael Strupp, Thomas Brandt<br />Jul  1, 2009; 2:223-239<br />Article]]></description>
<dc:creator>Michael Strupp, Thomas Brandt</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Review: Current treatment of vestibular, ocular motor disorders and nystagmus]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/1/25?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Recent and future advances in the treatment of status epilepticus]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/1/25?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Felix Rosenow, Susanne Knake<br />Jul  1, 2008; 1:25-32<br />Article]]></description>
<dc:creator>Felix Rosenow, Susanne Knake</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:identifier>10.1177/1756285608094263</dc:identifier>
<dc:title><![CDATA[Review: Recent and future advances in the treatment of status epilepticus]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/5/337?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Depression in epilepsy: mechanisms and therapeutic approach]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/5/337?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Marco Mula, Bettina Schmitz<br />Sep  1, 2009; 2:337-344<br />Article]]></description>
<dc:creator>Marco Mula, Bettina Schmitz</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Review: Depression in epilepsy: mechanisms and therapeutic approach]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/4/241?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Blood pressure and dementia -- a comprehensive review]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/4/241?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sean P. Kennelly, Brian A. Lawlor, Rose Anne Kenny<br />Jul  1, 2009; 2:241-260<br />Article]]></description>
<dc:creator>Sean P. Kennelly, Brian A. Lawlor, Rose Anne Kenny</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[Review: Blood pressure and dementia -- a comprehensive review]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/1/43?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Treatment of neuromyelitis optica: Current debate]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/1/43?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Tomoko Okamoto, Masafumi Ogawa,   Youwei Lin, Miho Murata, Sachiko Miyake, Takashi Yamamura<br />Jul  1, 2008; 1:43-52<br />Article]]></description>
<dc:creator>Tomoko Okamoto, Masafumi Ogawa,   Youwei Lin, Miho Murata, Sachiko Miyake, Takashi Yamamura</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:identifier>10.1177/1756285608093978</dc:identifier>
<dc:title><![CDATA[Review: Treatment of neuromyelitis optica: Current debate]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/1/13?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/1/13?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ida S. Haussleiter, Martin Brune, Georg Juckel<br />Jan  1, 2009; 2:13-29<br />Article]]></description>
<dc:creator>Ida S. Haussleiter, Martin Brune, Georg Juckel</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:identifier>10.1177/1756285608100325</dc:identifier>
<dc:title><![CDATA[Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/3/155?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Drug and nondrug treatment in tension-type headache]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/3/155?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Lars Bendtsen<br />May  1, 2009; 2:155-161<br />Article]]></description>
<dc:creator>Lars Bendtsen</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:identifier>10.1177/1756285609102328</dc:identifier>
<dc:title><![CDATA[Review: Drug and nondrug treatment in tension-type headache]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/3/181?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Comparing drug treatments in epilepsy]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/3/181?rss=1&amp;ssource=mfc</link>
<description><![CDATA[David Chadwick, Arif Shukralla, Tony Marson<br />May  1, 2009; 2:181-187<br />Article]]></description>
<dc:creator>David Chadwick, Arif Shukralla, Tony Marson</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:identifier>10.1177/1756285609102327</dc:identifier>
<dc:title><![CDATA[Review: Comparing drug treatments in epilepsy]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/5/299?rss=1&amp;ssource=mfc">
<title><![CDATA[Implementation of computer-based language therapy in aphasia]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/5/299?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Lisa M.D. Archibald, Joseph B. Orange, Donald J. Jamieson<br />Sep  1, 2009; 2:299-311<br />Article]]></description>
<dc:creator>Lisa M.D. Archibald, Joseph B. Orange, Donald J. Jamieson</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Implementation of computer-based language therapy in aphasia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/1/13?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/1/13?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rainer Surges, Kirill E. Volynski, Matthew C. Walker<br />Jul  1, 2008; 1:13-24<br />Article]]></description>
<dc:creator>Rainer Surges, Kirill E. Volynski, Matthew C. Walker</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:identifier>10.1177/1756285608094212</dc:identifier>
<dc:title><![CDATA[Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/1/5?rss=1&amp;ssource=mfc">
<title><![CDATA[What are the therapeutic advances in neurology? Opinions from world experts]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/1/5?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Gordon Mallarkey<br />Jul  1, 2008; 1:5-12<br />Article]]></description>
<dc:creator>Gordon Mallarkey</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:identifier>10.1177/1756285608094210</dc:identifier>
<dc:title><![CDATA[What are the therapeutic advances in neurology? Opinions from world experts]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/5/313?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: A review of the use of zonisamide in Parkinson's disease]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/5/313?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Pedro Emilio Bermejo, Buenaventura Anciones<br />Sep  1, 2009; 2:313-317<br />Article]]></description>
<dc:creator>Pedro Emilio Bermejo, Buenaventura Anciones</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Review: A review of the use of zonisamide in Parkinson's disease]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/5/319?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/5/319?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Albert C. Ludolph, Sarah Jesse<br />Sep  1, 2009; 2:319-326<br />Article]]></description>
<dc:creator>Albert C. Ludolph, Sarah Jesse</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/2/79?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: New treatment options in status epilepticus: a critical review on intravenous levetiracetam]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/2/79?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Eugen Trinka, Judith Dobesberger<br />Mar  1, 2009; 2:79-91<br />Article]]></description>
<dc:creator>Eugen Trinka, Judith Dobesberger</dc:creator>
<dc:date>2009-03-01</dc:date>
<dc:identifier>10.1177/1756285608100460</dc:identifier>
<dc:title><![CDATA[Review: New treatment options in status epilepticus: a critical review on intravenous levetiracetam]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/4/195?rss=1&amp;ssource=mfc">
<title><![CDATA[Monoclonal antibodies in multiple sclerosis treatment: current and future steps]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/4/195?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Claire L. Helliwell, Alasdair J. Coles<br />Jul  1, 2009; 2:195-203<br />Article]]></description>
<dc:creator>Claire L. Helliwell, Alasdair J. Coles</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:identifier>10.1177/1756285609337827</dc:identifier>
<dc:title><![CDATA[Monoclonal antibodies in multiple sclerosis treatment: current and future steps]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609347123v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Diagnosis and treatment of cerebral vasculitis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609347123v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Peter Berlit<br />Sep 28, 2009; 0:175628560<br />Article]]></description>
<dc:creator>Peter Berlit</dc:creator>
<dc:date>2009-09-28</dc:date>
<dc:title><![CDATA[Diagnosis and treatment of cerebral vasculitis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/1/51?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Cellular repair strategies in Parkinson's disease]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/1/51?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Beate Winner, Daniela M. Vogt-Weisenhorn, Chichung D. Lie, Ingmar Blumcke, Jurgen Winkler<br />Jan  1, 2009; 2:51-60<br />Article]]></description>
<dc:creator>Beate Winner, Daniela M. Vogt-Weisenhorn, Chichung D. Lie, Ingmar Blumcke, Jurgen Winkler</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:identifier>10.1177/1756285608100324</dc:identifier>
<dc:title><![CDATA[Review: Cellular repair strategies in Parkinson's disease]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/2/115?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/2/115?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Martin Stangel<br />Sep  1, 2008; 1:115-124<br />Article]]></description>
<dc:creator>Martin Stangel</dc:creator>
<dc:date>2008-09-01</dc:date>
<dc:identifier>10.1177/1756285608095747</dc:identifier>
<dc:title><![CDATA[Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/1/31?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: The potential for estrogens in preventing Alzheimer's disease and vascular dementia]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/1/31?rss=1&amp;ssource=mfc</link>
<description><![CDATA[James W. Simpkins, Evelyn Perez,   Xiaofei Wang,   ShaoHua Yang,   Yi Wen, Meharvan Singh<br />Jan  1, 2009; 2:31-49<br />Article]]></description>
<dc:creator>James W. Simpkins, Evelyn Perez,   Xiaofei Wang,   ShaoHua Yang,   Yi Wen, Meharvan Singh</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:identifier>10.1177/1756285608100427</dc:identifier>
<dc:title><![CDATA[Review: The potential for estrogens in preventing Alzheimer's disease and vascular dementia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/2/115?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Natalizumab in the treatment of multiple sclerosis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/2/115?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ozgur Yaldizli, Norman Putzki<br />Mar  1, 2009; 2:115-128<br />Article]]></description>
<dc:creator>Ozgur Yaldizli, Norman Putzki</dc:creator>
<dc:date>2009-03-01</dc:date>
<dc:identifier>10.1177/1756285608101861</dc:identifier>
<dc:title><![CDATA[Review: Natalizumab in the treatment of multiple sclerosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/4/205?rss=1&amp;ssource=mfc">
<title><![CDATA[The 39-item Parkinson's Disease Questionnaire (PDQ-39): is it a unidimensional construct?]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/4/205?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Peter Hagell, Maria H. Nilsson<br />Jul  1, 2009; 2:205-214<br />Article]]></description>
<dc:creator>Peter Hagell, Maria H. Nilsson</dc:creator>
<dc:date>2009-07-01</dc:date>
<dc:title><![CDATA[The 39-item Parkinson's Disease Questionnaire (PDQ-39): is it a unidimensional construct?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/2/99?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Progress in the treatment of myasthenia gravis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/2/99?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ralf Gold, Reinhard Hohlfeld, Klaus V. Toyka<br />Sep  1, 2008; 1:99-114<br />Article]]></description>
<dc:creator>Ralf Gold, Reinhard Hohlfeld, Klaus V. Toyka</dc:creator>
<dc:date>2008-09-01</dc:date>
<dc:identifier>10.1177/1756285608093888</dc:identifier>
<dc:title><![CDATA[Review: Progress in the treatment of myasthenia gravis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/2/93?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Primary CNS lymphoma]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/2/93?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Uwe Schlegel<br />Mar  1, 2009; 2:93-104<br />Article]]></description>
<dc:creator>Uwe Schlegel</dc:creator>
<dc:date>2009-03-01</dc:date>
<dc:identifier>10.1177/1756285608101222</dc:identifier>
<dc:title><![CDATA[Review: Primary CNS lymphoma]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/3/167?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Future perspectives for brain pharmacotherapies: implications of drug transport processes at the blood--brain barrier]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/3/167?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Dirk M. Hermann<br />Nov  1, 2008; 1:167-179<br />Article]]></description>
<dc:creator>Dirk M. Hermann</dc:creator>
<dc:date>2008-11-01</dc:date>
<dc:identifier>10.1177/1756285608097775</dc:identifier>
<dc:title><![CDATA[Review: Future perspectives for brain pharmacotherapies: implications of drug transport processes at the blood--brain barrier]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/5/291?rss=1&amp;ssource=mfc">
<title><![CDATA[Long-term daclizumab therapy in relapsing-remitting multiple sclerosis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/5/291?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Monica A. Rojas, Noel G. Carlson, Thomas L. Miller, John W. Rose<br />Sep  1, 2009; 2:291-297<br />Article]]></description>
<dc:creator>Monica A. Rojas, Noel G. Carlson, Thomas L. Miller, John W. Rose</dc:creator>
<dc:date>2009-09-01</dc:date>
<dc:title><![CDATA[Long-term daclizumab therapy in relapsing-remitting multiple sclerosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/2/75?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Therapeutic applications of hypothermia in cerebral ischaemia]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/2/75?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bruno P. Meloni, Frank L. Mastaglia, Neville W. Knuckey<br />Sep  1, 2008; 1:75-98<br />Article]]></description>
<dc:creator>Bruno P. Meloni, Frank L. Mastaglia, Neville W. Knuckey</dc:creator>
<dc:date>2008-09-01</dc:date>
<dc:identifier>10.1177/1756285608095204</dc:identifier>
<dc:title><![CDATA[Review: Therapeutic applications of hypothermia in cerebral ischaemia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/2/105?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/2/105?rss=1&amp;ssource=mfc</link>
<description><![CDATA[O.K. Sujith, Carol Lane<br />Mar  1, 2009; 2:105-113<br />Article]]></description>
<dc:creator>O.K. Sujith, Carol Lane</dc:creator>
<dc:date>2009-03-01</dc:date>
<dc:identifier>10.1177/1756285608101378</dc:identifier>
<dc:title><![CDATA[Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/3/181?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Escalating immunotherapy of multiple sclerosis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/3/181?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Peter Rieckmann, Anthony Traboulsee, Virginia Devonshire, Joel Oger<br />Nov  1, 2008; 1:181-192<br />Article]]></description>
<dc:creator>Peter Rieckmann, Anthony Traboulsee, Virginia Devonshire, Joel Oger</dc:creator>
<dc:date>2008-11-01</dc:date>
<dc:identifier>10.1177/1756285608098359</dc:identifier>
<dc:title><![CDATA[Review: Escalating immunotherapy of multiple sclerosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/1/7?rss=1&amp;ssource=mfc">
<title><![CDATA[Immunomodulation and postpartum relapses in patients with multiple sclerosis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/1/7?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kerstin Hellwig, Christian Beste, Sebastian Schimrigk, Andrew Chan<br />Jan  1, 2009; 2:7-11<br />Article]]></description>
<dc:creator>Kerstin Hellwig, Christian Beste, Sebastian Schimrigk, Andrew Chan</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:identifier>10.1177/1756285608100416</dc:identifier>
<dc:title><![CDATA[Immunomodulation and postpartum relapses in patients with multiple sclerosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/3/157?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/3/157?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Marinos C. Dalakas<br />Nov  1, 2008; 1:157-166<br />Article]]></description>
<dc:creator>Marinos C. Dalakas</dc:creator>
<dc:date>2008-11-01</dc:date>
<dc:identifier>10.1177/1756285608097463</dc:identifier>
<dc:title><![CDATA[Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/2/67?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Diagnosis and treatment of paroxysmal dyskinesias revisited]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/2/67?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Iris Unterberger, Eugen Trinka<br />Sep  1, 2008; 1:67-74<br />Article]]></description>
<dc:creator>Iris Unterberger, Eugen Trinka</dc:creator>
<dc:date>2008-09-01</dc:date>
<dc:identifier>10.1177/1756285608095119</dc:identifier>
<dc:title><![CDATA[Review: Diagnosis and treatment of paroxysmal dyskinesias revisited]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609337975v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Pathophysiology and treatment of bacterial meningitis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609337975v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Olaf Hoffman, Joerg R. Weber<br />Nov  1, 2009; 2:401-412<br />]]></description>
<dc:creator>Olaf Hoffman, Joerg R. Weber</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Review: Pathophysiology and treatment of bacterial meningitis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609337976v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609337976v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Philip L. De Jager<br />Nov  1, 2009; 2:369-377<br />]]></description>
<dc:creator>Philip L. De Jager</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/2/125?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Neutralizing antibodies against interferon-beta]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/2/125?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Per Soelberg Sorensen<br />Sep  1, 2008; 1:125-141<br />Article]]></description>
<dc:creator>Per Soelberg Sorensen</dc:creator>
<dc:date>2008-09-01</dc:date>
<dc:identifier>10.1177/1756285608095144</dc:identifier>
<dc:title><![CDATA[Review: Neutralizing antibodies against interferon-beta]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/3/193?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/3/193?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Claudia Bartels, Kira Spate, Henning Krampe, Hannelore Ehrenreich<br />Nov  1, 2008; 1:193-206<br />Article]]></description>
<dc:creator>Claudia Bartels, Kira Spate, Henning Krampe, Hannelore Ehrenreich</dc:creator>
<dc:date>2008-11-01</dc:date>
<dc:identifier>10.1177/1756285608098422</dc:identifier>
<dc:title><![CDATA[Review: Recombinant human erythropoietin: novel strategies for neuroprotective/neuroregenerative treatment of multiple sclerosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609339382v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Deep brain stimulation in Parkinson's disease]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609339382v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[S.J. Groiss, L. Wojtecki, M. Sudmeyer, A. Schnitzler<br />Nov  1, 2009; 2:379-391<br />]]></description>
<dc:creator>S.J. Groiss, L. Wojtecki, M. Sudmeyer, A. Schnitzler</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Review: Deep brain stimulation in Parkinson's disease]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609348902v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Treatment of dysautonomia in extrapyramidal disorders]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609348902v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Tjalf Ziemssen, Heinz Reichmann<br />Oct 14, 2009; 0:175628560<br />Article]]></description>
<dc:creator>Tjalf Ziemssen, Heinz Reichmann</dc:creator>
<dc:date>2009-10-14</dc:date>
<dc:title><![CDATA[Treatment of dysautonomia in extrapyramidal disorders]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/2/67?rss=1&amp;ssource=mfc">
<title><![CDATA[Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/2/67?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Francesco Patti, Maria Pia Amato, Stefano Bastianello, Luisa Caniatti, Elisabetta Di Monte, Fausto Lijoi, Benedetta Goretti, Silvia Messina, Orietta Picconi, Maria Rosalia Tola, Maria Trojano,   COGIMUS Study Group<br />Mar  1, 2009; 2:67-77<br />Article]]></description>
<dc:creator>Francesco Patti, Maria Pia Amato, Stefano Bastianello, Luisa Caniatti, Elisabetta Di Monte, Fausto Lijoi, Benedetta Goretti, Silvia Messina, Orietta Picconi, Maria Rosalia Tola, Maria Trojano,   COGIMUS Study Group</dc:creator>
<dc:date>2009-03-01</dc:date>
<dc:identifier>10.1177/1756285608101379</dc:identifier>
<dc:title><![CDATA[Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing--remitting multiple sclerosis: 2-year results from the COGIMUS study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/3/143?rss=1&amp;ssource=mfc">
<title><![CDATA[Progress in enzyme replacement therapy in glycogen storage disease type II]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/3/143?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Corrado Angelini, Claudio Semplicini, Paola Tonin, Massimiliano Filosto, Elena Pegoraro, Gianni Soraru, Marina Fanin<br />May  1, 2009; 2:143-153<br />Article]]></description>
<dc:creator>Corrado Angelini, Claudio Semplicini, Paola Tonin, Massimiliano Filosto, Elena Pegoraro, Gianni Soraru, Marina Fanin</dc:creator>
<dc:date>2009-05-01</dc:date>
<dc:identifier>10.1177/1756285609103324</dc:identifier>
<dc:title><![CDATA[Progress in enzyme replacement therapy in glycogen storage disease type II]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609349521v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Progress in the management of paraneoplastic neurological disorders]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609349521v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Hamid Sadeghian, Steven Vernino<br />Oct 13, 2009; 0:175628560<br />Article]]></description>
<dc:creator>Hamid Sadeghian, Steven Vernino</dc:creator>
<dc:date>2009-10-13</dc:date>
<dc:title><![CDATA[Progress in the management of paraneoplastic neurological disorders]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609344375v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609344375v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Amer Awad, Olaf Stuve<br />Nov  1, 2009; 2:357-368<br />]]></description>
<dc:creator>Amer Awad, Olaf Stuve</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/2/1/3?rss=1&amp;ssource=mfc">
<title><![CDATA[Do amyloid-lowering strategies work clinically?]]></title>
<link>http://tan.sagepub.com/cgi/content/short/2/1/3?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rob J. van Marum<br />Jan  1, 2009; 2:3-6<br />Article]]></description>
<dc:creator>Rob J. van Marum</dc:creator>
<dc:date>2009-01-01</dc:date>
<dc:identifier>10.1177/1756285608101376</dc:identifier>
<dc:title><![CDATA[Do amyloid-lowering strategies work clinically?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609339383v2?rss=1&amp;ssource=mfc">
<title><![CDATA[Review: Improving symptom control in early Parkinson's disease]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609339383v2?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Stuart H. Isaacson, Robert A. Hauser<br />Nov  1, 2009; 2:393-400<br />]]></description>
<dc:creator>Stuart H. Isaacson, Robert A. Hauser</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Review: Improving symptom control in early Parkinson's disease]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1756285609343480v1?rss=1&amp;ssource=mfc">
<title><![CDATA[Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1756285609343480v1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Carsten Lukas, Barbara Bellenberg, Horst K. Hahn, Jan Rexilius, Robert Drescher, Kerstin Hellwig, Odo Koster, Sebastian Schimrigk<br />Nov  1, 2009; 2:349-355<br />]]></description>
<dc:creator>Carsten Lukas, Barbara Bellenberg, Horst K. Hahn, Jan Rexilius, Robert Drescher, Kerstin Hellwig, Odo Koster, Sebastian Schimrigk</dc:creator>
<dc:date>2009-11-01</dc:date>
<dc:title><![CDATA[Benefit of repetitive intrathecal triamcinolone acetonide therapy in predominantly spinal multiple sclerosis: prediction by upper spinal cord atrophy]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://tan.sagepub.com/cgi/content/short/1/1/3?rss=1&amp;ssource=mfc">
<title><![CDATA[Editorial]]></title>
<link>http://tan.sagepub.com/cgi/content/short/1/1/3?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ralf Gold<br />Jul  1, 2008; 1:3-3<br />Article]]></description>
<dc:creator>Ralf Gold</dc:creator>
<dc:date>2008-07-01</dc:date>
<dc:identifier>10.1177/1756285608091657</dc:identifier>
<dc:title><![CDATA[Editorial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

</rdf:RDF>